UniProt ID | ZN226_HUMAN | |
---|---|---|
UniProt AC | Q9NYT6 | |
Protein Name | Zinc finger protein 226 | |
Gene Name | ZNF226 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 803 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in transcriptional regulation.. | |
Protein Sequence | MNMFKEAVTFKDVAVAFTEEELGLLGPAQRKLYRDVMVENFRNLLSVGHPPFKQDVSPIERNEQLWIMTTATRRQGNLGEKNQSKLITVQDRESEEELSCWQIWQQIANDLTRCQDSMINNSQCHKQGDFPYQVGTELSIQISEDENYIVNKADGPNNTGNPEFPILRTQDSWRKTFLTESQRLNRDQQISIKNKLCQCKKGVDPIGWISHHDGHRVHKSEKSYRPNDYEKDNMKILTFDHNSMIHTGQKSYQCNECKKPFSDLSSFDLHQQLQSGEKSLTCVERGKGFCYSPVLPVHQKVHVGEKLKCDECGKEFSQGAHLQTHQKVHVIEKPYKCKQCGKGFSRRSALNVHCKVHTAEKPYNCEECGRAFSQASHLQDHQRLHTGEKPFKCDACGKSFSRNSHLQSHQRVHTGEKPYKCEECGKGFICSSNLYIHQRVHTGEKPYKCEECGKGFSRPSSLQAHQGVHTGEKSYICTVCGKGFTLSSNLQAHQRVHTGEKPYKCNECGKSFRRNSHYQVHLVVHTGEKPYKCEICGKGFSQSSYLQIHQKAHSIEKPFKCEECGQGFNQSSRLQIHQLIHTGEKPYKCEECGKGFSRRADLKIHCRIHTGEKPYNCEECGKVFRQASNLLAHQRVHSGEKPFKCEECGKSFGRSAHLQAHQKVHTGDKPYKCDECGKGFKWSLNLDMHQRVHTGEKPYKCGECGKYFSQASSLQLHQSVHTGEKPYKCDVCGKVFSRSSQLQSHQRVHTGEKPYKCEICGKSFSWRSNLTVHHRIHVGDKSYKSNRGGKNIRESTQEKKSIK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
53 | Ubiquitination | SVGHPPFKQDVSPIE HCCCCCCCCCCCCCC | 51.90 | 21890473 | |
53 | Ubiquitination | SVGHPPFKQDVSPIE HCCCCCCCCCCCCCC | 51.90 | 21890473 | |
57 | Phosphorylation | PPFKQDVSPIERNEQ CCCCCCCCCCCCCCC | 28.57 | 21815630 | |
85 | Ubiquitination | LGEKNQSKLITVQDR CCCCCCCEEEEECCC | 33.86 | - | |
94 | Phosphorylation | ITVQDRESEEELSCW EEECCCCCHHHHHHH | 51.72 | - | |
175 | Ubiquitination | RTQDSWRKTFLTESQ ECCCHHHHHHCCHHH | 37.05 | - | |
193 | Sumoylation | RDQQISIKNKLCQCK HHHHHHHHHHHHHCC | 41.04 | - | |
193 | Ubiquitination | RDQQISIKNKLCQCK HHHHHHHHHHHHHCC | 41.04 | - | |
193 | Sumoylation | RDQQISIKNKLCQCK HHHHHHHHHHHHHCC | 41.04 | - | |
220 | Phosphorylation | DGHRVHKSEKSYRPN CCCCCCCCCCCCCCC | 35.07 | 24719451 | |
224 | Phosphorylation | VHKSEKSYRPNDYEK CCCCCCCCCCCCCCC | 40.95 | 24719451 | |
275 | Phosphorylation | DLHQQLQSGEKSLTC CHHHHHHCCCCCEEE | 58.47 | 28555341 | |
291 | Phosphorylation | ERGKGFCYSPVLPVH ECCCCCEECCCCCCC | 17.47 | 28450419 | |
292 | Phosphorylation | RGKGFCYSPVLPVHQ CCCCCEECCCCCCCC | 15.09 | 28450419 | |
386 | Phosphorylation | QDHQRLHTGEKPFKC HHHCCCCCCCCCCCC | 52.18 | 18669648 | |
389 | Sumoylation | QRLHTGEKPFKCDAC CCCCCCCCCCCCCCC | 58.04 | - | |
389 | Sumoylation | QRLHTGEKPFKCDAC CCCCCCCCCCCCCCC | 58.04 | - | |
401 | Phosphorylation | DACGKSFSRNSHLQS CCCCCCCCCCHHHHC | 37.33 | 17081983 | |
414 | Phosphorylation | QSHQRVHTGEKPYKC HCCCCCCCCCCCCCC | 44.15 | 29496963 | |
417 | Ubiquitination | QRVHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
417 | Sumoylation | QRVHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
417 | Sumoylation | QRVHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
419 | Phosphorylation | VHTGEKPYKCEECGK CCCCCCCCCCCCCCC | 39.06 | - | |
420 | Sumoylation | HTGEKPYKCEECGKG CCCCCCCCCCCCCCE | 43.63 | - | |
420 | Ubiquitination | HTGEKPYKCEECGKG CCCCCCCCCCCCCCE | 43.63 | - | |
420 | Sumoylation | HTGEKPYKCEECGKG CCCCCCCCCCCCCCE | 43.63 | - | |
442 | Phosphorylation | YIHQRVHTGEKPYKC EEECCCCCCCCCCCC | 44.15 | 29496963 | |
445 | Sumoylation | QRVHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
445 | Ubiquitination | QRVHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
445 | Sumoylation | QRVHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
447 | Phosphorylation | VHTGEKPYKCEECGK CCCCCCCCCCCCCCC | 39.06 | - | |
448 | Ubiquitination | HTGEKPYKCEECGKG CCCCCCCCCCCCCCC | 43.63 | - | |
448 | Sumoylation | HTGEKPYKCEECGKG CCCCCCCCCCCCCCC | 43.63 | - | |
448 | Sumoylation | HTGEKPYKCEECGKG CCCCCCCCCCCCCCC | 43.63 | - | |
470 | Phosphorylation | QAHQGVHTGEKSYIC CCCCCCCCCCCEEEE | 44.63 | 28555341 | |
498 | Phosphorylation | QAHQRVHTGEKPYKC HHHCCCCCCCCCEEC | 44.15 | 29496963 | |
501 | Ubiquitination | QRVHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
501 | Sumoylation | QRVHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
501 | Sumoylation | QRVHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
504 | Sumoylation | HTGEKPYKCNECGKS CCCCCCEECCCCCCC | 38.83 | - | |
504 | Sumoylation | HTGEKPYKCNECGKS CCCCCCEECCCCCCC | 38.83 | - | |
526 | Phosphorylation | QVHLVVHTGEKPYKC EEEEEEECCCCCEEE | 35.11 | 29496963 | |
529 | Sumoylation | LVVHTGEKPYKCEIC EEEECCCCCEEEEEC | 55.80 | - | |
529 | Ubiquitination | LVVHTGEKPYKCEIC EEEECCCCCEEEEEC | 55.80 | - | |
529 | Sumoylation | LVVHTGEKPYKCEIC EEEECCCCCEEEEEC | 55.80 | - | |
560 | Sumoylation | HSIEKPFKCEECGQG HCCCCCCCCCCCCCC | 49.62 | - | |
560 | Sumoylation | HSIEKPFKCEECGQG HCCCCCCCCCCCCCC | 49.62 | - | |
582 | Phosphorylation | QIHQLIHTGEKPYKC EEEEHHHCCCCCEEC | 39.79 | 29496963 | |
585 | Ubiquitination | QLIHTGEKPYKCEEC EHHHCCCCCEECCCC | 55.80 | - | |
587 | Phosphorylation | IHTGEKPYKCEECGK HHCCCCCEECCCCCC | 39.06 | - | |
588 | Sumoylation | HTGEKPYKCEECGKG HCCCCCEECCCCCCC | 43.63 | - | |
588 | Sumoylation | HTGEKPYKCEECGKG HCCCCCEECCCCCCC | 43.63 | - | |
588 | Ubiquitination | HTGEKPYKCEECGKG HCCCCCEECCCCCCC | 43.63 | - | |
610 | Phosphorylation | KIHCRIHTGEKPYNC EEEEEEECCCCCCCH | 44.67 | 27282143 | |
638 | Phosphorylation | LAHQRVHSGEKPFKC HHHCCHHCCCCCEEC | 45.87 | 20068231 | |
641 | Ubiquitination | QRVHSGEKPFKCEEC CCHHCCCCCEECHHH | 60.32 | - | |
644 | Sumoylation | HSGEKPFKCEECGKS HCCCCCEECHHHHHC | 49.62 | - | |
644 | Sumoylation | HSGEKPFKCEECGKS HCCCCCEECHHHHHC | 49.62 | - | |
694 | Phosphorylation | DMHQRVHTGEKPYKC CCCCCCCCCCCCEEC | 44.15 | 29496963 | |
697 | Ubiquitination | QRVHTGEKPYKCGEC CCCCCCCCCEECCCC | 55.80 | - | |
697 | Sumoylation | QRVHTGEKPYKCGEC CCCCCCCCCEECCCC | 55.80 | - | |
697 | Sumoylation | QRVHTGEKPYKCGEC CCCCCCCCCEECCCC | 55.80 | - | |
700 | Sumoylation | HTGEKPYKCGECGKY CCCCCCEECCCCHHH | 44.27 | - | |
700 | Sumoylation | HTGEKPYKCGECGKY CCCCCCEECCCCHHH | 44.27 | - | |
722 | Phosphorylation | QLHQSVHTGEKPYKC CCCCCHHCCCCCEEC | 44.90 | 29496963 | |
725 | Sumoylation | QSVHTGEKPYKCDVC CCHHCCCCCEECCCC | 55.80 | - | |
725 | Sumoylation | QSVHTGEKPYKCDVC CCHHCCCCCEECCCC | 55.80 | - | |
725 | Ubiquitination | QSVHTGEKPYKCDVC CCHHCCCCCEECCCC | 55.80 | - | |
750 | Phosphorylation | QSHQRVHTGEKPYKC HHCCCCCCCCCCEEE | 44.15 | 29496963 | |
753 | Ubiquitination | QRVHTGEKPYKCEIC CCCCCCCCCEEEEEC | 55.80 | - | |
753 | Sumoylation | QRVHTGEKPYKCEIC CCCCCCCCCEEEEEC | 55.80 | - | |
753 | Sumoylation | QRVHTGEKPYKCEIC CCCCCCCCCEEEEEC | 55.80 | - | |
782 | Phosphorylation | RIHVGDKSYKSNRGG EEEECCCCCCCCCCC | 42.40 | 24719451 | |
783 | Phosphorylation | IHVGDKSYKSNRGGK EEECCCCCCCCCCCC | 24.95 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN226_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN226_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN226_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SSBP3_HUMAN | SSBP3 | physical | 20211142 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...